Languages: English / Copyright: Public domain - Digital Collections - National Library of Medicine Search Results

Start Over Languages English ✖ Copyright Public domain ✖

41. Calculation of potential inflation-indexed rebates for Medicare Part B drugs

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2017
Subject(s):: Drug Costs
Insurance, Pharmaceutical Services -- economics
Medicare Part B -- economics
Cost Control
Cost Savings
Medicaid -- economics
Humans
United States
United States. Department of Health and Human Services.

42. Medicare Part B drug payments: impact of price substitutions based on 2014 average sales prices

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2017
Subject(s):: Drug Costs
Insurance, Health, Reimbursement
Insurance, Pharmaceutical Services
Medicare Part B -- economics
Cost Savings
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

43. Challenges appear to limit states' use of Medicaid payment suspensions

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2017
Subject(s):: Fraud -- prevention & control
Medicaid -- economics
State Government
Humans
United States
United States. Department of Health and Human Services.

44. Drug supply chain security: wholesalers exchange most tracing information

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2017
Subject(s):: Pharmaceutical Preparations -- supply & distribution
Prescription Drug Diversion
Information Dissemination
Security Measures
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

45. OHRP should inform potential complainants of how they can seek whistleblower protections:

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2017
Subject(s):: Human Experimentation
Research Subjects
Whistleblowing
Disclosure
Humans
United States
United States. Department of Health and Human Services.

46. Alaska State Medicaid Fraud Control Unit: 2016 onsite review

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2017
Subject(s):: Fraud -- prevention & control
Medicaid
Federal Government
State Government
Humans
Alaska
United States
United States. Department of Health and Human Services.

47. Kentucky State Medicaid Fraud Control Unit: 2017 onsite review

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2017
Subject(s):: Fraud -- prevention & control
Medicaid
Federal Government
State Government
Humans
Kentucky
United States
United States. Department of Health and Human Services.

48. Challenges remain in FDA's inspections of domestic food facilities

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2017
Subject(s):: Food Industry
Food Inspection
Food Safety
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

49. Enhancements needed in the tracking and collection of Medicare overpayments identified by ZPICS and PSCS

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2017
Subject(s):: Financial Audit
Insurance, Health, Reimbursement
Medicare -- economics
Contract Services
Durable Medical Equipment -- economics
Home Care Services -- economics
Hospice Care -- economics
Information Dissemination
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

50. A few states fell short in timely investigation of the most serious nursing home complaints: 2011-2015

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2017
Subject(s):: Nursing Homes
Quality Assurance, Health Care
Aged
Elder Abuse
State Government
Time Factors
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

51. Wyoming State Medicaid Fraud Control Unit: 2016 onsite review

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2017
Subject(s):: Fraud -- prevention & control
Medicaid
Federal Government
State Government
Humans
United States
Wyoming
United States. Department of Health and Human Services.

52. Medicare Part B drug payments: impact of price substitutions based on 2015 average sales prices

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2017
Subject(s):: Drug Costs
Insurance, Health, Reimbursement
Insurance, Pharmaceutical Services
Medicare -- economics
Cost Savings
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

53. Medicare payments for clinical diagnostic laboratory tests in 2016: year 3 of baseline data

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2017
Subject(s):: Clinical Laboratory Techniques -- economics
Insurance, Health, Reimbursement
Medicare Part B -- economics
Prospective Payment System
Rate Setting and Review
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

54. Excluding noncovered versions when setting payment for two Part B drugs would have resulted in lower drug costs for Medicare and its beneficiaries

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, November 2017
Subject(s):: Drug Costs
Insurance, Pharmaceutical Services -- economics
Medicare Part B -- economics
Prospective Payment System
Abatacept -- economics
Certolizumab Pegol -- economics
Cost Savings
Injections -- economics
Self Care -- economics
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)
Healthcare common procedure coding system

55. Medicaid Fraud Control Units: investigation and prosecution of fraud and beneficiary abuse in Medicaid personal care services

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, December 2017
Subject(s):: Fraud -- prevention & control
Homemaker Services
Medicaid
Elder Abuse
Government Regulation
State Government
Humans
United States
United States. Department of Health and Human Services.

56. Followup review: CMS's management of the quality payment program

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, December 2017
Subject(s):: Insurance, Health, Reimbursement
Medical Informatics
Medicare Part B -- economics
Quality of Health Care -- economics
Reimbursement, Incentive
Diffusion of Innovation
Fraud -- prevention & control
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

57. Potential misclassifications reported by drug manufacturers may have led to $1 billion in lost Medicaid rebates

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, December 2017
Subject(s):: Drug Costs
Drug Industry -- economics
Medicaid -- economics
Pharmaceutical Preparations -- classification
Pharmaceutical Preparations -- economics
Insurance, Health, Reimbursement
Insurance, Pharmaceutical Services
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

58. Entities' experiences and perceptions of reporting the theft, loss, or release of select agents or toxins to CDC

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, February 2018
Subject(s):: Biohazard Release
Mandatory Reporting
Toxins, Biological
Laboratories
Organizational Culture
Safety
Theft
Humans
United States
United States. Department of Health and Human Services.
Centers for Disease Control and Prevention (U.S.)

59. Drug supply chain security: dispensers received most tracing information

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, March 2018
Subject(s):: Pharmaceutical Preparations -- supply & distribution
Prescription Drug Diversion
Drug Industry
Information Dissemination
Pharmacies
Security Measures
Humans
United States
United States. Department of Health and Human Services.

60. Medicaid Fraud Control Units fiscal year 2017 annual report

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, March 2018
Subject(s):: Fraud -- prevention & control
Fraud -- statistics & numerical data
Medicaid
Federal Government
State Government
Humans
United States
United States. Department of Health and Human Services.

« Previous
Next »
1
2
3
4
5
6
7
…
2,725
2,726